Skip to main content
OpenTrials

Clinical trial condition

Epilepsy, Partial

Explore clinical trials studying Epilepsy, Partial. Study availability and eligibility vary by location and protocol.

18 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Epilepsy, Partial trial results

Completed

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00152451

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • N01191 108 Little Rock, Arkansas, United States
  • N01191 105 San Francisco, California, United States
  • N01191 102 Stanford, California, United States
  • N01191 107 Columbus, Ohio, United States
View Trial Details
Completed

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
Locations
  • Pfizer Investigational Site Bruges, Belgium
  • Pfizer Investigational Site Brussels, Belgium
  • Pfizer Investigational Site Leuven, Belgium
  • Pfizer Investigational Site Plovdiv, Bulgaria
View all 102 locations
View Trial Details
Completed

Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

NCT00355082

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
Locations
  • GSK Investigational Site Alabaster, Alabama, United States
  • GSK Investigational Site Litchfield Park, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View all 103 locations
View Trial Details
Completed

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00113165

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
Locations
  • GSK Investigational Site Anniston, Alabama, United States
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Northport, Alabama, United States
  • GSK Investigational Site Tuscaloosa, Alabama, United States
View all 148 locations
View Trial Details

Related conditions